C1QTNF6
Reactivity: Human
ELISA
Host: Rabbit
Polyclonal
HRP
Application Notes
ELISA: (direct or indirect: 1:200-1:500). Immunohistochemistry (paraffin sections): 1:200. Western blot: (1:200-1:500 using ECL. Suggested blocking and dilution buffer is PBST with 0.05 % Tween 20 and 5 % skim milk. Suggested incubation time is 1 hour at room temperature). Optimal conditions should be determined individually for each application.
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Liquid. 0.2um-filtered solution in PBS, pH 7.4. Contains no preservatives.
Preservative
Without preservative
Storage
-20 °C
Storage Comment
Stable for at least 1 year after receipt when stored at -20°C.
Target
CTRP6 (C1QTNF6)
(Complement C1q Tumor Necrosis Factor-Related Protein 6 (C1QTNF6))
MGC148634 antibody, CTFP6 antibody, CTRP6 antibody, ZACRP6 antibody, 2810036M19Rik antibody, Ctrp6 antibody, C1q and TNF related 6 antibody, C1q and tumor necrosis factor related protein 6 antibody, C1QTNF6 antibody, C1qtnf6 antibody
Background
CTRP6 mediates the phosphorylation of AMPK and acetyl-CoA carboxylase (ACC) in skeletal muscle cells, subsequently mediating glycogen accumulation and fatty acid oxidation. It induces the expression of the potent anti-inflammatory cytokine IL-10 in macrophages. CTRP6 may be a potential serum marker for hepatocellular carcinoma, contributing to tumor angiogenesis by activating the Akt pathway. CTRP6 was also shown to be associated with obesity, type 1 diabetes mellitus (T1D), vitiligo (depigmentation of the skin) and ASFV (African Swine Fever Virus). CTRP6 forms homotrimers and higher-order oligomers and it may also form heteromeric complexes with CTRP1. May be involved in kidney inflammation.